IRIS
SARAO, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.152
AS - Asia 2.478
EU - Europa 1.279
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 56
OC - Oceania 8
Totale 9.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.049
SG - Singapore 1.207
CN - Cina 462
BR - Brasile 390
IT - Italia 340
HK - Hong Kong 232
VN - Vietnam 210
UA - Ucraina 174
DE - Germania 150
RU - Federazione Russa 138
BD - Bangladesh 117
FR - Francia 111
IE - Irlanda 72
GB - Regno Unito 71
FI - Finlandia 70
IN - India 56
CA - Canada 52
TR - Turchia 52
AR - Argentina 36
SE - Svezia 32
NL - Olanda 27
IQ - Iraq 21
AT - Austria 20
MX - Messico 20
PL - Polonia 19
CO - Colombia 18
EC - Ecuador 18
KR - Corea 18
JP - Giappone 17
BE - Belgio 15
PK - Pakistan 13
ZA - Sudafrica 13
ID - Indonesia 12
UZ - Uzbekistan 9
PY - Paraguay 8
SA - Arabia Saudita 8
EG - Egitto 7
ES - Italia 7
CL - Cile 6
KE - Kenya 6
MA - Marocco 6
PE - Perù 6
VE - Venezuela 6
AU - Australia 5
HN - Honduras 5
TG - Togo 5
TN - Tunisia 5
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LT - Lituania 4
OM - Oman 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
AZ - Azerbaigian 3
BO - Bolivia 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
PR - Porto Rico 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GY - Guiana 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
Totale 9.455
Salva come PNG Salva come JPEG
Città #
Ashburn 523
Singapore 496
Fairfield 429
Woodbridge 379
Chandler 360
San Jose 295
Ann Arbor 283
Houston 250
Beijing 234
Hong Kong 227
Council Bluffs 186
Seattle 173
Wilmington 158
Cambridge 132
Boardman 117
Jacksonville 95
Lauterbourg 83
Los Angeles 82
Dearborn 75
Dublin 72
Princeton 72
Ho Chi Minh City 61
New York 57
Elk Grove Village 48
Dallas 45
Izmir 45
Santa Clara 45
Hanoi 40
Buffalo 39
Udine 37
Redondo Beach 35
Milan 31
São Paulo 28
Munich 27
Ogden 26
San Diego 25
Norwalk 23
Chicago 22
Dong Ket 22
Helsinki 22
Frankfurt am Main 21
Hefei 18
Phoenix 18
Warsaw 18
Seoul 17
The Dalles 17
Orem 16
Des Moines 15
Toronto 15
Brussels 14
Belluno 13
Brooklyn 13
Rome 13
Belo Horizonte 12
Düsseldorf 12
Mumbai 12
Stockholm 12
Denver 11
Montreal 11
Porto Alegre 11
Rio de Janeiro 11
Wuhan 11
Amsterdam 10
Bologna 10
Naples 10
Shenzhen 10
Vienna 10
Falls Church 9
Manchester 9
Nuremberg 9
San Francisco 9
Tokyo 9
Atlanta 8
Da Nang 8
Lappeenranta 8
Ottawa 8
Redmond 8
Tashkent 8
Treviso 8
Turin 8
Baghdad 7
Guangzhou 7
Mexico City 7
Nanjing 7
Paese 7
Quito 7
Shanghai 7
Boston 6
Brasília 6
Chengdu 6
Curitiba 6
Hangzhou 6
Johannesburg 6
London 6
New Delhi 6
Bắc Ninh 5
Campinas 5
Chennai 5
Dhaka 5
Grafing 5
Totale 5.991
Salva come PNG Salva come JPEG
Nome #
Triamcinolone acetonide for the treatment of diabetic macular oedema 225
A case of CRB1-negative Coats-like retinitis pigmentosa 195
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 193
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 188
Neovascular age-related macular degeneration 181
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 176
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 171
Proliferative Diabetic Retinopathy: Treatment Update 171
Fluocinolone acetonide for the treatment of diabetic macular edema 170
Dexamethasone implant in diabetic macular edema in real-life situations 169
Online optical coherence tomography during subthreshold laser irradiation 165
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 158
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 157
Pharmacotherapy for treatment of retinal vein occlusion. 155
Author’s response 155
Optical coherence tomography angiography findings in diabetic retinopathy 154
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 154
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 145
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 144
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 142
Update on combination therapy in wet age-related macular degeneration 138
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 135
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 135
Safety of 6000 intravitreal dexamethasone implants 132
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis 131
Drug safety evaluation of intravitreal triamcinolone acetonide 130
Macular pucker 127
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 126
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 126
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 125
The Present and Future of Optic Pathway Glioma Therapy 122
Intravitreal steroids for the treatment of retinal diseases. 122
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 122
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 120
Regression of diabetic macular edema after subcutaneous exenatide. 117
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 117
Surgical Management for Diabetic Macular Edema 113
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 113
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study) 112
Steroids in a Combination Strategy 112
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 111
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 110
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 105
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 105
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 103
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 101
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 96
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 95
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 94
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study) 89
Edema maculare post occlusione venosa 88
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 88
Impact on quality of life 87
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 84
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 84
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 84
Validation of Esaso Classification of Diabetic Maculopathy 81
Stem cell therapy in retinal diseases: current evidence 81
Fundamental principles of an effective diabetic retinopathy screening program 81
Present Status of Laser Therapy: Role of Subthreshold Laser 80
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 79
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) 75
Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers 74
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 74
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 73
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 73
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 72
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 68
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 67
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD 66
Macular Holes 66
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 66
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 66
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 66
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 65
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 65
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 63
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 63
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 62
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 62
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 60
OCT angiography in chronic central serous chorioretinopathy 60
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 60
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 59
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 58
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 55
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema – How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck Retina 53
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD 52
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 49
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study 45
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 41
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study 32
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study 30
RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis 16
Comment to: Hashiya N, Maruko I, Maruko R et al. Increased intraocular pressure immediately after aflibercept 8 mg intravitreal injection for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2026) 264:1611–1617. doi:10.1007/s00417-026-07117-3 15
Immediate Sequential Bilateral Cataract Surgery: Are We Overstating the Case? [Letter] 14
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication 7
Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants 7
Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study 7
Totale 9.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022403 0 0 9 7 14 22 35 23 18 84 101 90
2022/2023758 96 51 7 121 82 179 0 71 97 4 31 19
2023/2024261 46 17 7 6 35 30 11 26 37 15 2 29
2024/20251.560 27 97 100 76 27 51 113 68 183 138 246 434
2025/20263.352 322 409 276 355 472 204 306 116 192 272 259 169
2026/2027634 174 153 307 0 0 0 0 0 0 0 0 0
Totale 9.775